Chinese Food and Drug Administration (CFDA)

Partner of STA Pharmaceutical, Ascletis, has been granted approval by the Chinese Food and Drug Administration (CFDA) for its Category 1 new drug, Ganovo (also known as Danoprevir or ASC08) to treat viral hepatitis C. Read more


Horizon Discovery Group has entered into a partnership with a life sciences company focused on accelerating the standardisation of diagnostic testing in China, Genewell Biotechnology. Read more


STA Pharmaceutical has reported rapid growth in companies intending to market their products in China using it as a partner following the CFDA announcement of the Market Authorization Holder (MAH) pilot programme last year Read more


Swiss pharmaceutical group, Helsinn, has opened an office in Shanghai, China, as part of the group’s commitment to the region — Helsinn Pharmaceuticals (Beijing). Read more